Anupam Rasayan India Ltd

Anupam Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anupam Rasayan India Ltd

₹ 1,093 3.87%
10 Jun 3:10 p.m.
anupamrasayan.com BSE: 543275 NSE: ANURAS
About

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

Key Points

Business Verticals FY24
1) Life Science Specialty Chemicals (91%):
a. Agrochemicals (65%)- Manufactures agro intermediates and agro active ingredients (insecticides, fungicides, and herbicides) for the agrochemical industry.
b. Personal Care (17%) - Manufactures antibacterial and ultraviolet protection intermediates and ingredients for the personal care industry.
c. Pharmaceuticals (9%)- The segment focuses on developing intermediates and ‘key starting materials’ for active pharmaceutical ingredients.

Website BSE NSE
  • Market Cap ₹ 12,013 Cr.
  • Current Price ₹ 1,093
  • High / Low ₹ 1,101 / 601
  • Stock P/E 129
  • Book Value ₹ 259
  • Dividend Yield 0.12 %
  • ROCE 7.33 %
  • ROE 3.33 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 4.07 times its book value
  • Company has a low return on equity of 5.39% over last 3 years.
  • Dividend payout has been low at 8.51% of profits over last 3 years
  • Company has high debtors of 186 days.
  • Promoter holding has decreased over last 3 years: -4.00%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE 500 BSE SmallCap BSE Allcap BSE Commodities BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
325 344 393 392 480 386 392 296 401 254 294 390 500
220 245 282 281 363 285 285 216 308 201 214 266 356
Operating Profit 105 99 111 111 117 101 107 79 93 53 80 124 144
OPM % 32% 29% 28% 28% 24% 26% 27% 27% 23% 21% 27% 32% 29%
-7 -8 -10 -3 24 12 3 2 12 6 2 -4 6
Interest 14 12 16 14 20 18 20 25 26 22 27 32 31
Depreciation 15 16 18 18 19 19 20 20 21 21 22 29 31
Profit before tax 68 62 67 75 103 77 71 36 58 16 34 59 88
Tax % 33% 32% 29% 28% 29% 32% 31% 28% 30% 25% 10% 9% 29%
46 42 48 54 73 52 49 26 40 12 31 54 63
EPS in Rs 4.60 3.96 4.15 4.00 5.28 3.59 3.78 1.68 2.82 0.36 1.52 2.56 4.05
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
502 529 811 1,074 1,602 1,475 1,437
408 394 617 769 1,171 1,094 1,036
Operating Profit 93 135 194 305 431 381 401
OPM % 19% 25% 24% 28% 27% 26% 28%
19 11 26 8 10 30 11
Interest 24 45 69 31 63 89 112
Depreciation 23 29 52 60 71 80 102
Profit before tax 66 72 100 222 308 242 198
Tax % 24% 26% 30% 31% 30% 31% 19%
49 53 70 152 217 167 160
EPS in Rs 9.85 10.64 7.04 15.18 16.84 11.72 8.49
Dividend Payout % 0% 0% 7% 7% 15% 11% 0%
Compounded Sales Growth
10 Years: %
5 Years: 22%
3 Years: 10%
TTM: -3%
Compounded Profit Growth
10 Years: %
5 Years: 12%
3 Years: -15%
TTM: -26%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 19%
1 Year: 36%
Return on Equity
10 Years: %
5 Years: 6%
3 Years: 5%
Last Year: 3%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 50 50 100 100 107 110 110
Reserves 432 515 1,473 1,627 2,265 2,651 2,740
694 847 423 836 822 1,070 1,373
146 252 301 327 584 771 1,045
Total Liabilities 1,323 1,664 2,298 2,891 3,778 4,602 5,269
681 977 1,115 1,202 1,417 1,501 2,185
CWIP 191 101 43 44 120 609 216
Investments 0 0 0 149 67 67 9
451 586 1,140 1,496 2,173 2,424 2,860
Total Assets 1,323 1,664 2,298 2,891 3,778 4,602 5,269

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
39 95 1 -171 292 59 -30
-250 -178 -193 -412 -523 -392 -330
206 102 416 384 371 395 223
Net Cash Flow -6 19 224 -199 140 62 -137

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 88 89 92 95 95 143 186
Inventory Days 277 515 530 852 483 627 876
Days Payable 105 226 215 225 167 247 348
Cash Conversion Cycle 260 379 408 722 410 524 715
Working Capital Days 168 185 233 328 253 344 454
ROCE % 9% 10% 11% 13% 9% 7%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
65.17% 65.16% 60.96% 60.80% 60.77% 60.73% 61.41% 61.26% 61.23% 61.23% 61.19% 61.19%
4.98% 4.59% 8.19% 8.52% 9.79% 10.26% 9.13% 8.07% 7.14% 7.00% 7.46% 6.47%
4.40% 4.40% 6.18% 4.98% 3.74% 1.76% 2.51% 2.56% 2.56% 2.30% 2.32% 2.25%
25.45% 25.84% 24.67% 25.68% 25.71% 27.25% 26.96% 28.10% 29.06% 29.47% 29.06% 30.11%
No. of Shareholders 65,87071,49273,32666,50761,50461,12960,08957,62362,21863,86660,93857,478

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls